MARKET

ADGM

ADGM

Adagio Medical
NASDAQ
1.000
-0.010
-0.99%
Closed 15:26 02/12 EST
OPEN
1.040
PREV CLOSE
1.010
HIGH
1.040
LOW
0.9800
VOLUME
13.85K
TURNOVER
--
52 WEEK HIGH
2.870
52 WEEK LOW
0.6250
MARKET CAP
21.18M
P/E (TTM)
-0.2104
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ADGM last week (0202-0206)?
Weekly Report · 4d ago
Adagio Medical highlights favorable safety profile in cardiac ablation study
TipRanks · 02/04 14:20
Adagio Medical Announced the Publication of Results From the US Early Feasibility Study Evaluating Ultralow Temperature Cardiac Ablation for Scar-related Ventricular Tachycardia
Benzinga · 02/04 13:10
Adagio Medical Unveils Promising Results for Ultralow Temperature Ablation in Ventricular Tachycardia Study
Reuters · 02/04 13:02
Adagio Medical Holdings to Participate at BTIG Annual MedTech Conference
Reuters · 02/02 13:05
Weekly Report: what happened at ADGM last week (0126-0130)?
Weekly Report · 02/02 09:47
Adagio Medical to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Barchart · 02/02 07:05
Lake Street Reaffirms Their Buy Rating on Adagio Medical Holdings (ADGM)
TipRanks · 01/29 13:56
More
About ADGM
Adagio Medical Holdings, Inc. is a commercial stage medical device company. It is focused on developing proprietary Ultra-Low Temperature Cryoablation technology that creates contiguous, transmural lesions to treat cardiac arrhythmias, with an emphasis on ventricular tachycardia. It is developing and placing on the European Union (EU) market ablation technologies for the treatment of cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. Its product portfolio consists of three product families: iCLAS atrial ULTC catheter and accessories, vCLAS ventricular ULTC catheter, and Cryopulse atrial PFCA catheter and accessories. All of these catheters share the same ULTC cryoablation console. The iCLAS system is CE-marked with the indication for treatment of paroxysmal atrial fibrillation, persistent atrial fibrillation and atrial flutter. The vCLAS ventricular catheter has been specifically designed for the treatment of ventricular arrhythmia.

Webull offers Adagio Medical Holdings Inc stock information, including NASDAQ: ADGM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADGM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ADGM stock methods without spending real money on the virtual paper trading platform.